Edge Wealth Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Edge Wealth Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-75	Closed	-$2K	–	631
2018 Q1	$2K	Hold	75	–	–	﹤0.01%	516
2017 Q4	$3K	Hold	75	–	–	﹤0.01%	474
2017 Q3	$4K	Hold	75	–	–	﹤0.01%	462
2017 Q2	$4K	Hold	75	–	–	﹤0.01%	453
2017 Q1	$3K	Hold	75	–	–	﹤0.01%	446
2016 Q4	$2K	Hold	75	–	–	﹤0.01%	439
2016 Q3	$2K	Hold	75	–	–	﹤0.01%	444
2016 Q2	$2K	Sell	75 -1,500	-95%	-$37K	﹤0.01%	415
2016 Q1	$32K	Buy	1,575 +1,425	+950%	+$45.2K	0.01%	200
2015 Q4	$8K	Hold	150	–	–	﹤0.01%	315
2015 Q3	$6K	Hold	150	–	–	﹤0.01%	338
2015 Q2	$7K	Hold	150	–	–	﹤0.01%	324
2015 Q1	$6K	Buy	+150	New	+$5.15K	﹤0.01%	339

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Edge Wealth Management's PTLA Position: Q2 2018 in Review

Edge Wealth Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2018, closing a stake of 75 shares — an estimated $2K sold.

Edge Wealth Management first reported a position in PTLA in Q1 2015 and held it in 13 quarters. The position peaked at $32K in Q1 2016. 204 funds tracked by Wall St. Rank hold PTLA as of Q2 2018.

Edge Wealth Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Edge Wealth Management sold 75 Portola Pharmaceuticals, Inc. shares in Q2 2018, an estimated $2K.
Edge Wealth Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 13 quarters.
Edge Wealth Management's Portola Pharmaceuticals, Inc. position peaked at $32K in Q1 2016.
204 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2018.

Based on Edge Wealth Management's 13F filing for Q2 2018, filed 17 Jul 2018.